MELISSA MCCARTER: Open Payments
NPI 1699771972 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,638 in 118 payments from 36 companies in 2025. Trend: 2023 $3,004 · 2024 $2,762 · 2025 $2,638
Food & beverage: $2,638
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $215 |
| Celgene Corporation | 9 | $207 |
| Gilead Sciences, Inc. | 5 | $165 |
| PFIZER INC. | 9 | $160 |
| ABBVIE INC. | 9 | $141 |
| Daiichi Sankyo Inc. | 6 | $135 |
| Merck Sharp & Dohme LLC | 5 | $131 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| SOBI, INC | 2 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
Products named: Trodelvy, ENHERTU, KEYTRUDA, IMBRUVICA, REBLOZYL, Doptelet, CARVYKTI, TECVAYLI.
Industry payments across SC — which companies pay providers there.
